Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure

Molecular and Cellular Biology

Volumn 33, Issue 10, 2013, Pages 2016-2028

  Lee, Sei Jung ^a   Leoni, Giovanna ^a   Neumann, Philipp Alexander ^a   Chun, Jerold ^b   Nusra, Asma ^a   Yuna, C Chris ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDIC ACID RECEPTOR 1; PHOSPHOLIPASE C BETA; RECEPTOR; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ISOENZYME; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID; NEUROPEPTIDE; PLCB1 PROTEIN, MOUSE; PLCB2 PROTEIN, MOUSE; RAC PROTEIN; RAC1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; HOMEOSTASIS; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WOUND CLOSURE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL MOTION; CELL NUCLEUS; CYTOLOGY; DUODENUM; EPITHELIUM CELL; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETICS; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WOUND HEALING;

MUS;

ANIMALS; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; DUODENUM; EPITHELIAL CELLS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HOMEOSTASIS; INTESTINAL MUCOSA; ISOENZYMES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEUROPEPTIDES; PHOSPHOLIPASE C BETA; PROTEIN BINDING; PROTEIN TRANSPORT; RAC GTP-BINDING PROTEINS; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; WOUND HEALING;

MLCS; MLOWN;

EID: 84878971521     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00038-13     Document Type: Article

References (51)

1. Crosnier C, Stamataki D, Lewis J. 2006. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7:349-359.
2. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. 2010. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 50:157-186.
3. Mutoh T, Rivera R, Chun J. 2012. Insights into the pharmacological relevance of lysophospholipid receptors. Br. J. Pharmacol. 165:829-844.
4. Sturm A, Sudermann T, Schulte KM, Goebell H, Dignass AU. 1999. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology 117:368-377.
5. Lin S, Yeruva S, He P, Singh AK, Zhang H, Chen M, Lamprecht G, de Jonge HR, Tse M, Donowitz M, Hogema BM, Chun J, Seidler U, Yun CC. 2010. Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2. Gastroenterology 138:649-658.
6. Lee SJ, Ritter SL, Zhang H, Shim H, Hall RA, Yun CC. 2011. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells. Gastroenterology 140:924-934.
7. Lin S, Lee SJ, Shim H, Chun J, Yun CC. 2010. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 299:G1128-G1138.
8. Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar PL, Nelson DJ, Tigyi GJ, Naren AP. 2005. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J. Exp. Med. 202: 975-986.
9. Yun CC, Sun H, Wang D, Rusovici R, Castleberry A, Hall RA, Shim H. 2005. LPA2 receptor mediates mitogenic signals in human colon cancer cells. Am. J. Physiol. Cell Physiol. 289:C2-C11.
10. Suh PG, Park JI, Manzoli L, Cocco L, Peak JC, Katan M, Fukami K, Kataoka T, Yun S, Ryu SH. 2008. Multiple roles of phosphoinositidespecific phospholipase C isozymes. BMB Rep. 41:415-434.
11. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, Yagi M, Sato M, Suzuki R, Murooka H, Sakai T, Nishitoba T, Im DS, Nochi H, Tamoto K, Tomura H, Okajima F. 2003. Ki16425, a subtype-selective antagonist for EDGfamily lysophosphatidic acid receptors. Mol. Pharmacol. 64:994-1005.
12. Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T, Kuwabara A, Yanagita Y, Ikeya T, Tanahashi Y, Ogawa T, Ohwada S, Morishita Y, Ohta H, Im DS, Tamoto K, Tomura H, Okajima F. 2004. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J. Biol. Chem. 279:6595-6605.
13. Yun CH, Lamprecht G, Forster DV, Sidor A. 1998. NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H+ exchanger NHE3 and the cytoskeletal protein ezrin. J. Biol. Chem. 273: 25856-25863.
14. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. 1993. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 90:587-591.
15. Gilchrist A, Bunemann M, Li A, Hosey MM, Hamm HE. 1999. A dominant-negative strategy for studying roles ofGproteins in vivo. J. Biol. Chem. 274:6610-6616.
16. Contos JJ, Fukushima N, Weiner JA, Kaushal D, Chun J. 2000. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. U. S. A. 97:13384-13389.
17. He P, Lee SJ, Lin S, Seidler U, Lang F, Fejes-Toth G, Naray-Fejes-Toth A, Yun CC. 2011. Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+exchanger NHE3 by glucocorticoids. Mol. Biol. Cell 22:3812-3825.
18. Zhang H, Wang D, Sun H, Hall RA, Yun CC. 2007. MAGI-3 regulates LPA-induced activation of Erk and RhoA. Cell Signal. 19:261-268.
19. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. 2004. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21:491-501.
20. Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, Lehr HA, GallePR, Neurath MF. 2005. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54:950-954.
21. Manieri NA, Drylewicz MR, Miyoshi H, Stappenbeck TS. 2012. Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. Gastroenterology 143:110-121.
22. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206:1465-1472.
23. Lin S, Wang D, Iyer S, Ghaleb AM, Shim H, Yang VW, Chun J, Yun CC. 2009. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology 136:1711-1720.
24. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:238-249.
25. Nava P, Koch S, Laukoetter MG, Lee WY, Kolegraff K, Capaldo CT, Beeman N, Addis C, Gerner-Smidt K, Neumaier I, Skerra A, Li L, Parkos CA, Nusrat A. 2010. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 32:392-402.
26. Reed SI. 1992. The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8:529-561.
27. Beauchamp RD, Sheng HM, Shao JY, Thompson EA, Ko TC. 1996. Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1. Ann. Surg. 223:620-628.
28. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R, Ohta H, Yamori T, Watanabe M, Chun J, Arai H. 2004. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 279:17634-17639.
29. Van Leeuwen FN, Olivo C, Grivell S, Giepmans BN, Collard JG, Moolenaar WH. 2003. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J. Biol. Chem. 278:400-406.
30. Snyder JT, Singer AU, Wing MR, Harden TK, Sondek J. 2003. The pleckstrin homology domain of phospholipase C-beta2 as an effector site for Rac. J. Biol. Chem. 278:21099-21104.
31. Harden TK, Sondek J. 2006. Regulation of phospholipase C isozymes by ras superfamily GTPases. Annu. Rev. Pharmacol. Toxicol. 46:355-379.
32. Notcovich C, Diez F, Tubio MR, Baldi A, Kazanietz MG, Davio C, Shayo C. 2010. Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways. Exp. Cell Res. 316:401-411.
33. Harmon B, Ratner L. 2008. Induction of the Gαq signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J. Virol. 82:9191-9205.
34. Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Clezardin P, Peyruchaud O. 2006. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc. Natl. Acad. Sci. U. S. A. 103:9643-9648.
35. Ma L, Matsumoto M, Xie W, Inoue M, Ueda H. 2009. Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J. Neurochem. 109:603-610.
36. Xu A, Suh PG, Marmy-Conus N, Pearson RB, Seok OY, Cocco L, Gilmour RS. 2001. Phosphorylation of nuclear phospholipase C beta1 by extracellular signal-regulated kinase mediates the mitogenic action of insulin- like growth factor I. Mol. Cell. Biol. 21:2981-2990.
37. Avazeri N, Courtot AM, Pesty A, Duquenne C, Lefevre B. 2000. Cytoplasmic and nuclear phospholipase C-beta 1 relocation: role in resumption of meiosis in the mouse oocyte. Mol. Biol. Cell 11:4369-4380.
38. Willard FS, Crouch MF. 2000. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol. Cell Biol. 78:387-394.
39. Waters CM, Saatian B, Moughal NA, Zhao Y, Tigyi G, Natarajan V, Pyne S, Pyne NJ. 2006. Integrin signalling regulates the nuclear localization and function of the lysophosphatidic acid receptor-1 (LPA1) in mammalian cells. Biochem. J. 398:55-62.
40. Gobeil F, Fortier A, Zhu T, Bossolasco M, Leduc M, Grandbois M, Heveker N, Bkaily G, Chemtob S, Barbaz D. 2006. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can. J. Physiol. Pharmacol. 84:287-297.
41. O'Carroll SJ, Mitchell MD, Faenza I, Cocco L, Gilmour RS. 2009. Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the cyclin D3-cdk4 complex. Cell Signal. 21:926-935.
42. Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D, Vitale M, Castorina S, Suh PG, Cocco L. 2000. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J. Biol. Chem. 275:30520-30524.
43. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
44. Illenberger D, Schwald F, Pimmer D, Binder W, Maier G, Dietrich A, Gierschik P. 1998. Stimulation of phospholipase C-beta2 by the Rho GTPases Cdc42Hs and Rac1. EMBO J. 17:6241-6249.
45. Gennero I, Laurencin-Dalicieux S, Conte-Auriol F, Briand-Mesange F, Laurencin D, Rue J, Beton N, Malet N, Mus M, Tokumura A, Bourin P, Vico L, Brunel G, Oreffo RO, Chun J, Salles JP. 2011. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Bone 49:395-403.
46. Estivill-Torrus G, Llebrez-Zayas P, Matas-Rico E, Santin L, Pedraza C, De Diego I, Del Arco I, Fernandez-Llebrez P, Chun J, De Fonseca FR. 2008. Absence of LPA1 signaling results in defective cortical development. Cereb. Cortex 18:938-950.
47. Hecht JH, Weiner JA, Post SR, Chun J. 1996. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1071-1083.
48. Dusaulcy R, Daviaud D, Pradere JP, Gres S, Valet P, Saulnier-Blache JS. 2009. Altered food consumption in mice lacking lysophosphatidic acid receptor-1. J. Physiol. Biochem. 65:345-350.
49. Tanaka T, Kassai A, Ohmoto M, Morito K, Kashiwada Y, Takaishi Y, Urikura M, Morishige J, Satouchi K, Tokumura A. 2012. Quantification of phosphatidic acid in foodstuffs using a thin-layer-chromatographyimaging technique. J. Agric. Food Chem. 60:4156-4161.
50. Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD. 2008. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14:45-54.
51. Pradere JP, Klein J, Gres S, Guigne C, Neau E, Valet P, Calise D, Chun J, Bascands JL, Saulnier-Blache JS, Schanstra JP. 2007. LPA1 receptor activation promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 18: 3110-3118.